Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene

Carcinogenesis

Volumn 17, Issue 9, 1996, Pages 2069-2072

  Aldaz, C Marcelo ^a   Liao, Qiao Yin ^a   LaBate, Michael ^a   Johnston, Dennis A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DIMETHYLBENZ[A]ANTHRACENE; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER INCIDENCE; CONTROLLED STUDY; DRUG INDUCED CANCER; FEMALE; GENE MUTATION; LATENT PERIOD; MOUSE; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; PRIORITY JOURNAL;

EID: 0029791362     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.9.2069     Document Type: Article

References (22)

1. Welsch, C.W. (1985) Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res., 45, 3415-3443.
2. Medina, D. (1982) Mammary Tumors. In Homburger, F. (ed.), The Mouse in Biomedical Research. Academic Press, New York, vol. IV, pp. 373-396.
3. Medina, D. (1974) Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB/c and C57BL mice. J Natl hist., 53, 213-221.
4. 1 mice. Cancer Res., 40, 368-373.
5. Aldaz, C.M., Chen, A., Gollahon, L.S., Russo, J. and Zappler, K. (1992) Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression. Cancer Res., 52, 4791-4798.
6. Gollahon, L.S., Chen, A. and Aldaz, C.M. (1995) Loss of heterozygosity at chromosome 1q loci in rat mammary tumors. Mol. Carcinogen., 12, 7-13.
7. Levan, G., Szpirer, J., Szpirer, C., Klinga, K., Hanson, C. and Islam, M. (1991) The gene map of the Norway rat (Rattus norvegicus) and comparative mapping with mouse and man. Genomics, 10, 699-718.
8. Medina, D. (1974) Mammary tumorigenesis in chemical carcinogen-treated mice. II. Dependence on hormone stimulation for tumorigenesis. J. Natl Cancer Inst., 53, 223-226.
9. Guzman, R.C., Osborn, R.C., Swanson, S.M., Sakthivel, R., Hwang, S.-I., Miyamoto, S. and Nandi, S. (1992) Incidence of c-Ki-ras activation in N-methyl-N-nitrosourea-induced mammary carcinomas in pituitary-isografted mice. Cancer Res., 52, 5732-5737.
10. Pazos, P., Lanari, C., Meiss, R., Charreau, E.H. and Pasqualini, C.D. (1991) Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice. Breast Cancer Res. Treatment, 20, 133-138.
11. DiGiovanni, J., Beltrán, L., Rupp, A., Harvey, R.G. and Gill, R.D. (1993) Further analysis of c-Ha-ras mutations in papillomas initiated by several polycyclic aromatic hydrocarbons and papillomas from uninitiated, promoter-treated skin in SENCAR mice. Mol. Carcinogen., 8, 272-279.
12. George, D.L., Scott, A.F., Trusko, S., Glick, B., Ford, E. and Dorney, D.J. (1985) Structure and expression of amplified c-Ki-ras gene sequences in Y1 mouse adrenal tumor cells. EMBO J., 4, 1199-1203.
13. Orita, M., Suzuki, Y., Sekiya, T. and Hayashi, K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics, 5, 874-879.
14. Brenner, A.J. and Aldaz, C.M. (1995) Chromosome 9p allelic loss and p16/ CDKN2 mutational analysis in uncultured breast tumors. Evidence of p16 inactivation in immortal breast epithelial lines. Cancer Res., 55, 2892-2895.
15. Russo, I.H. and Russo, J. (1991) Progestagens and mammary gland development: Differentiation versus carcinogenesis. Acta Endocrinol. (Copenhagan), 125, 7-12.
16. Chilvers, C. (1994) Breast cancer and depot-medroxyprogesterone acetate: A review. Contraception, 49, 211-222.
17. Skegg, D.C.G., Noonan, E.A., Paul, C., Spears, G.F.S., Meirik, O. and Thomas, D.B. (1995) Depot medroxyprogesterone acetate and breast cancer. JAMA, 273, 799-804.
18. Lanari, C., Molinolo, A.A. and Pasqualini, C.D. (1986) Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice. Cancer Lett., 33, 215-223.
19. Russo, I.H. and Russo, J. (1988) Hormone prevention of mammary carcinogenesis: A new approach in anticancer research. Anticancer Res., 8, 1247-1264.
20. Labrie, F., Li.S., Bélanger, A., Côté, J., Mérand, Y. and Lepage, M. (1993) Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced tumors induced by dimethylbenz|a|anthracene in the rat. Breast Cancer Res. Treatment, 26, 253-265.
21. Dandekar, S., Sukumar, S., Zarbl, H., Young, L.J.T. and Cardiff, R.D. (1986) Specific activation of the cellular Harvey-ras oncogene in dimethyl-benzanthracene-induced mouse mammary tumors. Molec. Cell. Biol., 6, 4104-4108.
22. Kumar, R., Medina, D. and Sukumar, S. (1990) Activation of Ha-ras oncogenes in preneoplastic mouse mammary tissues. Oncogene, 5, 1271-1277.